Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2024-02-27 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
112年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 95% confidence The document contains detailed information about dividend distribution, including cash dividends per share, dates of board resolutions and shareholder meetings, and explanations of dividend policies. It is a formal announcement of dividend amounts and payment details for shareholders. The document length is short (1944 characters) and focuses solely on dividend distribution data without broader financial statements or analysis. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2024-02-27 Chinese
公告本公司董事會通過112年度合併財務報告
Annual Report Classification · 95% confidence The document is a public announcement from a listed company (1789 神隆) reporting that the board of directors has approved the consolidated financial report for the fiscal year 112 (2023). It includes detailed financial figures such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity for the full year period 112/01/01 to 112/12/31. The document is 908 characters long, which is relatively short but contains substantive financial data and analysis for a full fiscal year. It is not merely an announcement of a report being published or attached, but the actual financial summary approved by the board. Therefore, it fits the definition of an Annual Report (10-K) or equivalent yearly financial report. Given the context and content, the best classification is Annual Report (10-K).
2024-02-27 Chinese
113年2月6日內部人設質解質
Director's Dealing Classification · 100% confidence The document is a tabular report showing changes in pledged shares by a company director or related party, including details such as the number of shares pledged and released, dates, and involved parties. This matches the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives. The document length is short and focused solely on share pledging activity, not a broader financial or management report.
2024-02-15 Chinese
113年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 神隆, providing information about loan balances and endorsement guarantees for the current and previous months. It contains tabulated financial data but is very short (624 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of specific financial information rather than a full report or announcement of a report. There is no indication of an annual or interim report, audit report, or earnings release. The content fits best as a general regulatory announcement or compliance filing that does not fit into more specific categories.
2024-02-07 Chinese
113年1月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a brief summary report of monthly and cumulative net operating revenue figures for a company named 神隆, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is only 768 characters, indicating it is a short summary rather than a full report. There is no indication that this is an announcement of a report publication or a regulatory filing. Given the concise nature and focus on key financial figures, this fits best as a Fund Information / Factsheet (FS) type document, which is a brief summary of key company facts and financials.
2024-02-07 Chinese
113年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors and their related parties, with specific numbers of shares held, changes in holdings, and classifications of shares. The content focuses on insider share ownership and transactions, which is typical of a Director's Dealing report. There is no indication of financial statements, earnings data, or management commentary, nor is it an announcement of voting results or capital changes. The document is not a report publication announcement or a certification. Therefore, the document is best classified as a Director's Dealing report.
2024-02-02 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.